TANDEM DIABETES CARE INC TNDM

About TANDEM DIABETES CARE INC (TNDM): stock profile, AI score and financials

TANDEM DIABETES CARE INC (TNDM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TNDM at 42.9/100 on a composite quality score built from its SEC filings, placing it at rank #1,988 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include free cash flow (22.7) and balance sheet strength (23.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 16.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), TANDEM DIABETES CARE INC reports quarterly revenue of $254.6M, net income of $-21.2M, an operating margin of -5.4%. Top institutional holders of TNDM by reported 13-F value include BlackRock, Sessa Capital IM, L.P., LINDEN ADVISORS, based on the most recent SEC filings. TNDM trades on the Nasdaq exchange and files with the SEC under CIK 1438133. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TNDM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TANDEM DIABETES CARE INC directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1438133 →